CoChat

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice

Costello, Fiona, Stüve, Olaf, Weber, Martin S, Zamvil, Scott S, Frohman, Elliot · 2007 · Current Opinion in Neurology

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: To outline the scientific rationale for combination therapy in multiple sclerosis and to discuss the evidence for combination treatment strategies from animal models and clinical trials of multiple sclerosis. RECENT FINDINGS: Experiments conducted in experimental autoimmune encephalomyelitis have recently shown beneficial effects of numerous combination therapies. The combination of approved and experimental drugs and two or more experimental agents may positively impact clinical disease activity, inflammation within the central nervous system, and neurorepair. Clinical trials are currently underway to establish the therapeutic efficacy and safety of various combination therapies for multiple sclerosis patients. SUMMARY: More effective therapies are needed to treat multiple sclerosis. There are good scientific rationales for the use of combination therapy in multiple sclerosis, and the pharmacologic principles for evaluating and understanding their actions are available. The evaluation of specific combination therapies in the controlled setting of clinical trials should be a priority in clinical multiple sclerosis research.

Overview

Integrity signals

Registry

Crossref · 10.1097/wco.0b013e328122de1b

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 3

  1. Reid, 1995, J Hum Hypertens, 9, S19
  2. Zamvil, 1990, Annu Rev Immunol, 8, 579, 10.1146/annurev.iy.08.040190.003051 · doi:10.1146/annurev.iy.08.040190.003051 · Paper page
  3. Cohen, 2003, Mult Scler, 9, S139

Cited by

See all 47

Metadata

Authors
Costello, F., Stüve, O., Weber, M. S., Zamvil, S. S., & Frohman, E.
Affiliations
  • University of Ottawa (CA)
  • VA North Texas Health Care System (US)
  • University of California, San Francisco (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Costello, Fiona
Venue
Current Opinion in Neurology
Published
2007-06
Volume
20
Issue
3
Pages
281-285
ISSN
1350-7540 (ISSN-L)
OpenAlex
W1994457578
Cited by
46
References
46
Citations by year
2026: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 1
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Keywords
multiple sclerosis, combination therapy, experimental autoimmune encephalomyelitis, neurorepair, neuroinflammation, disease activity, investigational drugs, clinical trials
MeSH terms
Glatiramer Acetate, Animals, Antibodies, Monoclonal, Clinical Protocols, Clinical Trials as Topic, Drug Therapy, Combination, Humans, Immunologic Factors, Immunotherapy, Multiple Sclerosis, Peptides, Interferon-beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. https://app.cochat.ai/papers/10.1097/wco.0b013e328122de1b
The paper
Costello, F., Stüve, O., Weber, M. S., Zamvil, S. S., & Frohman, E. (2007). Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. Current Opinion in Neurology. https://doi.org/10.1097/wco.0b013e328122de1b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.